IRENOTECAN (CPT-11) IN ADVANCED RENAL-CELL CARCINOMA - RESULTS OF A MULTI DOSE STUDY DEFINING THE MINIMAL EFFECTIVE DOSE USING A MODEL OF ADVANCED RENAL-CELL CARCINOMA (RCC)

Authors
KEANE TE HARRIS WB SUN C KARR J PETROS JA GRAHAM SD
Citation
Te. Keane et al., IRENOTECAN (CPT-11) IN ADVANCED RENAL-CELL CARCINOMA - RESULTS OF A MULTI DOSE STUDY DEFINING THE MINIMAL EFFECTIVE DOSE USING A MODEL OF ADVANCED RENAL-CELL CARCINOMA (RCC), The Journal of urology, 159(5), 1998, pp. 751-751
Citations number
NO
Categorie Soggetti
Urology & Nephrology
Journal title
The Journal of urology → ACNP
ISSN journal
00225347
Volume
159
Issue
5
Year of publication
1998
Supplement
S
Pages
751 - 751
Database
ISI
SICI code
0022-5347(1998)159:5<751:I(IARC>2.0.ZU;2-G